Elk Grove Village, IL—(ENEWSPF)—December 31, 2015. A federal study suggests the childhood “asthma epidemic” may be levelling off or even declining after years of steady increases, but not among poor children. Researchers at the National Center for Health Statistics analyzed asthma rates between 2001 and 2013 for the study, “Changing[Read More…]
Health and Fitness
Children With Epilepsy Need Plans To Stop Prolonged Seizures At School
Elk Grove Village, IL—(ENEWSPF)—December 31, 2015. To prevent a child with epilepsy from having a prolonged seizure that becomes a medical crisis, a new American Academy of Pediatrics (AAP) clinical report says health providers, families and schools should collaborate on plans for managing the child or adolescent with epilepsy, which[Read More…]
New NIH-funded Memory Drug Moves Into Phase 1 Clinical Study
Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition Bethesda, Maryland–(ENEWSPF)–December 31, 2015. An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the[Read More…]
ACLU Files Lawsuit Against Hospital for Denying Reproductive Health Care
Dignity Health Hospital Network Continues to Refuse Pregnancy-Related Care Because of Religious Directives WASHINGTON –(ENEWSPF)–December 29, 2015. The ACLU and the law firm of Covington & Burling LLP have filed a lawsuit challenging Dignity Health’s use of religious directives to deny basic reproductive health care to its patients. Filed on[Read More…]
At New Hampshire Town Hall, Hillary Clinton Highlights Plan to Make Alzheimer’s Cure Possible by 2025
NEW HAMPSHIRE—(ENEWSPF)—December 29, 2015. At a midday town hall meeting in Portsmouth, NH, Clinton continued to talk about her newly released, $2 billion-per-year plan to prevent, effectively treat and make a cure possible for Alzheimer’s by 2025. Clinton noted that Alzheimer’s is the sixth leading cause of death in the[Read More…]
Federal Judge Blocks Missouri Department of Health From Revoking Planned Parenthood’s Abortion License in Columbia
Kansas City –(ENEWSPF)–December 29, 2015. Today, U.S. District Judge Nanette Laughrey issued a preliminary injunction blocking Missouri’s Department of Health and Senior Services from revoking Planned Parenthood of Kansas and Mid-Missouri’s license to perform abortions in its Columbia health center. “Judge Laughrey’s decision affirms the state of Missouri violated the[Read More…]
Statement by Secretary Burwell on End of Ebola Transmission in Guinea, Dec. 29, 2015
Washington, DC–(ENEWSPF)–December 29, 2015 “Today we mark an important milestone in our fight against Ebola. The World Health Organization has declared the end of Ebola virus transmission in Guinea – marking the first time the West Africa region has stopped the original chains of transmission that started the outbreak two[Read More…]
CDC Year in Review: What’s Next?
Atlanta, GA–(ENEWSPF)–December 28, 2015. Today, CDC reviews the most pressing public health challenges of 2015 and previews plans for 2016. CDC has made significant strides combatting some of the biggest threats to Americans’ health, including infectious and chronic diseases. In 2015, CDC helped lead global efforts to slow Ebola transmissions[Read More…]
FDA Approves Zurampic to Treat High Blood Uric Acid Levels Associated with Gout
Silver Spring, Maryland–(ENEWSPF)–December 22, 2015. The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric[Read More…]
FDA Approves New Orphan Drug to Treat Pulmonary Arterial Hypertension
Silver Spring, Maryland–(ENEWSPF)–December 22, 2015. On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. “Uptravi offers an additional treatment option[Read More…]





